Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1912 1
1922 2
1925 1
1929 1
1932 2
1933 3
1934 1
1935 1
1936 2
1939 1
1945 2
1946 3
1947 1
1948 5
1949 1
1950 6
1951 3
1952 1
1953 2
1954 10
1955 4
1956 6
1957 3
1958 3
1959 2
1960 3
1961 4
1962 7
1963 6
1964 11
1965 12
1966 5
1967 9
1968 7
1969 5
1970 10
1971 16
1972 7
1973 11
1974 15
1975 19
1976 18
1977 26
1978 18
1979 11
1980 26
1981 23
1982 27
1983 32
1984 33
1985 26
1986 21
1987 35
1988 23
1989 27
1990 23
1991 31
1992 37
1993 34
1994 36
1995 24
1996 26
1997 27
1998 35
1999 28
2000 51
2001 40
2002 46
2003 66
2004 48
2005 60
2006 70
2007 70
2008 80
2009 69
2010 67
2011 68
2012 97
2013 80
2014 76
2015 80
2016 92
2017 88
2018 106
2019 106
2020 130
2021 144
2022 123
2023 88
2024 106
2025 109
2026 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,827 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial.
Siva S, Bressel M, Sidhom M, Sridharan S, Vanneste BGL, Davey R, Montgomery R, Ruben J, Foroudi F, Higgs B, Lin C, Raman A, Hardcastle N, Hofman MS, De Abreu Lourenco R, Shaw M, Mancuso P, Moon D, Wong LM, Lawrentschuk N, Wood S, Brook NR, Kron T, Martin J, Pryor D; FASTRACK II Investigator Group. Siva S, et al. Among authors: shaw m. Lancet Oncol. 2024 Mar;25(3):308-316. doi: 10.1016/S1470-2045(24)00020-2. Lancet Oncol. 2024. PMID: 38423047 Clinical Trial.
Manuscript Clarification.
Peart DJ, Balsalobre-Fernández C, Shaw MP. Peart DJ, et al. Among authors: shaw mp. J Strength Cond Res. 2020 Dec;34(12):e277. doi: 10.1519/JSC.0000000000003366. J Strength Cond Res. 2020. PMID: 33235022 No abstract available.
Prostate Cancer Diagnosis: Biopsy Approaches.
Gravestock P, Shaw M, Veeratterapillay R, Heer R. Gravestock P, et al. Among authors: shaw m. In: Barber N, Ali A, editors. Urologic Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 12. Chapter 12. In: Barber N, Ali A, editors. Urologic Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 12. Chapter 12. PMID: 36343126 Free Books & Documents. Review.
A cycling, progenitor-like cell population at the base of atypical teratoid rhabdoid tumor subtype differentiation trajectories.
Blanco-Carmona E, Paassen I, He J, DeMartino J, Büllesbach A, Anderson N, Buhl JL, Federico A, Mauermann M, Brok M, Straathof K, Behjati S, Vibhakar R, Donson AM, Foreman NK, Shaw M, Frühwald MC, Korshunov A, Hasselblatt M, Thomas C, Franke N, Kranendonk MEG, Hoving EW, Jäger N, Johann PD, Pfister SM, Filbin MG, Kool M, Drost J. Blanco-Carmona E, et al. Among authors: shaw m. Neuro Oncol. 2025 Dec 1;27(12):3260-3275. doi: 10.1093/neuonc/noaf179. Neuro Oncol. 2025. PMID: 40726147 Free PMC article.
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study results.
Hamilton EP, Patel MR, Borges VF, Meisel JL, Okera M, Alemany CA, Pluard TJ, Wesolowski R, Sabanathan D, Miller KD, Conlin AK, McCarthy N, Shaw M, Tonda M, Shilkrut M, Lin NU. Hamilton EP, et al. Among authors: shaw m. Breast Cancer Res. 2025 Jul 1;27(1):119. doi: 10.1186/s13058-025-02049-y. Breast Cancer Res. 2025. PMID: 40598566 Free PMC article. Clinical Trial.
Mesoscale standing wave imaging.
Foylan S, Schniete JK, Kölln LS, Dempster J, Hansen CG, Shaw M, Bushell TJ, McConnell G. Foylan S, et al. Among authors: shaw m. J Microsc. 2024 Jul;295(1):33-41. doi: 10.1111/jmi.13189. Epub 2023 May 17. J Microsc. 2024. PMID: 37156549 Free article.
Evidence-Based Oncology™ Special Issue: ASCO Recap.
Caffrey M, Shaw ML, Mattina C. Caffrey M, et al. Among authors: shaw ml. Am J Manag Care. 2022 Jul;28(5 Spec No.):SP223-SP290. doi: 10.37765/ajmc.2022.sp05. Am J Manag Care. 2022. PMID: 35877810
Reply of the authors.
Nelson SM, Alrashid K, Shaw M, Anderson RA. Nelson SM, et al. Among authors: shaw m. Fertil Steril. 2025 Feb;123(2):374. doi: 10.1016/j.fertnstert.2024.09.019. Epub 2024 Sep 16. Fertil Steril. 2025. PMID: 39293572 Free article. No abstract available.
2,827 results